Wednesday, February 10, 2010, 6:12am EST - Canadian Markets open in 3 hours and 18 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

BioClinica, Inc. (BIOC)

 On Feb 9: 4.46 USD   0.00 (0.00%)  
MORE ON BIOC
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
BioClinica, Inc (NGM:BIOC) Delayed quote dataEdit
Last Trade: 4.46 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 4.46
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 8.00
Day's Range: N/A - N/A
52wk Range: 2.85 - 5.93
Volume: 0
Avg Vol (3m): 17,674.6
Market Cap: 64.19M
P/E (ttm): 36.26
EPS (ttm): 0.12
Div & Yield: N/A (N/A%)
BioClinica, Inc. (BIOC)
1d  5d  3m  6m  1y  2y  5y  max 
 Add BIOC to Portfolio   Download Data

HEADLINES
• BioClinica Inks Multi-Year Outsourcing Deal with Leading Biopharmaceutical Company
Business Wire (Thu, Feb 4)
• BioClinica to Release Fourth Quarter and Year-End 2009 Financial Results on February 10, 2010
Business Wire (Wed, Feb 3)
• Robert Sammis Joins BioClinica as VP of Finance for eClinical Division
Business Wire (Tue, Feb 2)
• BioClinica to Present at Jefferies 2010 Global Healthcare Services Conference on January 27, 2010
Business Wire (Wed, Jan 20)
• BioClinica to Present at Sidoti & Companys First 2010 Micro Cap Conference on January 11, 2010
Business Wire (Tue, Jan 5)
• BioClinica Honored as Technology Company of the Year at Eastern Technology Councils Enterprise Awards
Business Wire (Tue, Dec 8)
• BIOCLINICA INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
EDGAR Online (Mon, Nov 23)
• BIOCLINICA INC Financials
EDGAR Online Financials (Wed, Nov 11)
• BIOCLINICA INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
• BioClinica, Inc. Earnings Call scheduled for 11:00 am ET today
CCBN (Wed, Nov 4)
More Headlines for BIOC...
ANALYST
EPS Est (next year) (Dec-09) : 0.19
EPS Est (in 2 years) (Dec-10) : 0.30
Avg Rec (current)*: 2.0
PEG Ratio: 2.37
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
BioClinica, Inc. operates as a global provider of clinical trials services, helping to support drug and product development efforts through various phases of the clinical trial process.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices